Cargando…
Sibutramine as a Cause of Sudden Cardiac Death
Importance. Sibutramine was withdrawn from the US market due to association with adverse cardiovascular outcomes especially with patients having preexisting cardiac disease. However, continued presence of sibutramine in herbal medications is a concern to public safety. Results. We report a case of a...
Autores principales: | Rodriguez-Guerra, Miguel, Yadav, Mayank, Bhandari, Manoj, Sinha, Archna, Bella, Jonathan N., Sklyar, Eduard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884177/ https://www.ncbi.nlm.nih.gov/pubmed/33628521 http://dx.doi.org/10.1155/2021/8896932 |
Ejemplares similares
-
Sibutramine on Cardiovascular Outcome
por: Scheen, André J.
Publicado: (2011) -
Phentermine, Sibutramine and Affective Disorders
por: An, Hoyoung, et al.
Publicado: (2013) -
Cardiovascular Safety Pharmacology of Sibutramine
por: Yun, Jaesuk, et al.
Publicado: (2015) -
Sibutramine-Induced Nonischemic Cardiomyopathy
por: Shah, Meet S, et al.
Publicado: (2022) -
Cardiac Evaluation and Monitoring of Patients Undergoing Noncardiac Surgery
por: Rafiq, Arsalan, et al.
Publicado: (2017)